What is Egyptian International Pharmaceutical Investments Book Value per Share?
Egyptian International Pharmaceutical Investments's book value per share for the quarter that ended in Dec. 2023 was E£28.62.
During the past 12 months, Egyptian International Pharmaceutical Investments's average Book Value Per Share Growth Rate was 13.90% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 8.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 5.10% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was 9.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the book value growth rate using book value per share data.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Egyptian International Pharmaceutical Investments was 18.70% per year. The lowest was 2.10% per year. And the median was 5.65% per year.
Egyptian International Pharmaceutical Investments's current price is E£41.81. Its book value per share for the quarter that ended in Dec. 2023 was E£28.62. Hence, today's PB Ratio of Egyptian International Pharmaceutical Investments is 1.46.
During the past 13 years, the highest P/B Ratio of Egyptian International Pharmaceutical Investments was 15.53. The lowest was 0.94. And the median was 2.44.
Egyptian International Pharmaceutical Investments Book Value per Share Historical Data
The historical data trend for Egyptian International Pharmaceutical Investments's Book Value per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Egyptian International Pharmaceutical Investments Book Value per Share Chart
Egyptian International Pharmaceutical Investments Annual Data
Competitive Comparison of Egyptian International Pharmaceutical Investments's Book Value per Share
For the Drug Manufacturers - Specialty & Generic subindustry, Egyptian International Pharmaceutical Investments's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Egyptian International Pharmaceutical Investments's PB Ratio Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Egyptian International Pharmaceutical Investments's PB Ratio distribution charts can be found below:
* The bar in red indicates where Egyptian International Pharmaceutical Investments's PB Ratio falls into.
Egyptian International Pharmaceutical Investments Book Value per Share Calculation
Egyptian International Pharmaceutical Investments's Book Value Per Share for the fiscal year that ended in Dec. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Book value may include intangible items which may come from the company's past acquisitions. Book value less intangibles is called Tangible Book.
Egyptian International Pharmaceutical Investments (CAI:PHAR) Book Value per Share Explanation
Usually a company's book value and Tangible Book per Share may not reflect its true value. The assets may be carried on the balance sheets at the original cost minus depreciation. This may underestimate the true economic values of the assets. It also may over-estimate their true economic value because the assets can become obsolete.
For financial companies such as banks and insurance companies, their assets may be reported in current market value of the assets owned. Book values of financial companies are more accurate indicator of the economic value of the company.
Egyptian International Pharmaceutical Investments Book Value per Share Related Terms
Thank you for viewing the detailed overview of Egyptian International Pharmaceutical Investments's Book Value per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Egyptian International Pharmaceutical Investments (CAI:PHAR) Business Description
Egyptian International Pharmaceutical Investments is an Egypt based company pharmaceutical generic drugs. It holds license agreements with a group of pharmaceutical companies to produce their products locally and replace the imported ones. The company produces dosage forms, Spansule capsules, non-traditional dosage forms including soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets. It exports its products to Arab countries, African, Asian and East European Countries. Its products portfolio includes antibiotics, anesthetics, analgesics, antihypertensives, cholesterol-lowering medications, ophthalmic products, blood substitutes and restoratives, dermatological drugs and vitamins. Some of its products are Vasotec, Co-vasotec, Flumox, and Cefotax.
Egyptian International Pharmaceutical Investments (CAI:PHAR) Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CAI:PHAR has been successfully added to your 